Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Gabriel Rinnerthaler; Simon Peter Gampenrieder; Andreas Petzer; Sonja Burgstaller; David Fuchs; Dieter Rossmann; Marija Balic; Daniel Egle; Holger Rumpold; Christian F. Singer; Rupert Bartsch; Edgar Petru; Thomas Melchardt; Hanno Ulmer; Brigitte Mlineritsch; Richard Greil

doi:10.1186/s12885-018-4979-0

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, Sonja Burgstaller, David Fuchs, Dieter Rossmann, Marija Balic, Daniel Egle, Holger Rumpold, Christian F. Singer, Rupert Bartsch, Edgar Petru, Thomas Melchardt, Hanno Ulmer, Brigitte Mlineritsch, Richard Greil

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1074
Pages (from-to)	1074
Number of pages	9
Journal	BMC Cancer
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s12885-018-4979-0
Publication status	Published - 2018

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

JKU Focus areas

Medical Sciences (in general)
Health System Research
Clinical Research on Aging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12885-018-4979-0

Cite this

Rinnerthaler, G., Gampenrieder, S. P., Petzer, A., Burgstaller, S., Fuchs, D., Rossmann, D., Balic, M., Egle, D., Rumpold, H., Singer, C. F., Bartsch, R., Petru, E., Melchardt, T., Ulmer, H., Mlineritsch, B., & Greil, R. (2018). Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial). BMC Cancer, 18(1), 1074. Article 1074. https://doi.org/10.1186/s12885-018-4979-0

@article{7927674f25f642e0afde7469359a5fb6,

title = "Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)",

author = "Gabriel Rinnerthaler and Gampenrieder, {Simon Peter} and Andreas Petzer and Sonja Burgstaller and David Fuchs and Dieter Rossmann and Marija Balic and Daniel Egle and Holger Rumpold and Singer, {Christian F.} and Rupert Bartsch and Edgar Petru and Thomas Melchardt and Hanno Ulmer and Brigitte Mlineritsch and Richard Greil",

year = "2018",

doi = "10.1186/s12885-018-4979-0",

language = "English",

volume = "18",

pages = "1074",

journal = "BMC Cancer",

issn = "1471-2407",

number = "1",

}

Rinnerthaler, G, Gampenrieder, SP, Petzer, A, Burgstaller, S, Fuchs, D, Rossmann, D, Balic, M, Egle, D, Rumpold, H, Singer, CF, Bartsch, R, Petru, E, Melchardt, T, Ulmer, H, Mlineritsch, B & Greil, R 2018, 'Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)', BMC Cancer, vol. 18, no. 1, 1074, pp. 1074. https://doi.org/10.1186/s12885-018-4979-0

TY - JOUR

T1 - Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

AU - Rinnerthaler, Gabriel

AU - Gampenrieder, Simon Peter

AU - Petzer, Andreas

AU - Burgstaller, Sonja

AU - Fuchs, David

AU - Rossmann, Dieter

AU - Balic, Marija

AU - Egle, Daniel

AU - Rumpold, Holger

AU - Singer, Christian F.

AU - Bartsch, Rupert

AU - Petru, Edgar

AU - Melchardt, Thomas

AU - Ulmer, Hanno

AU - Mlineritsch, Brigitte

AU - Greil, Richard

PY - 2018

Y1 - 2018

UR - https://www.ncbi.nlm.nih.gov/pubmed/30400780

U2 - 10.1186/s12885-018-4979-0

DO - 10.1186/s12885-018-4979-0

M3 - Article

SN - 1471-2407

VL - 18

SP - 1074

JO - BMC Cancer

JF - BMC Cancer

IS - 1

M1 - 1074

ER -

Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

Fields of science

JKU Focus areas

UN SDGs

Access to Document

Other files and links

Cite this